PMC:7441788 / 36541-36717 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T144","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T380","span":{"begin":10,"end":12},"obj":"Chemical"}],"attributes":[{"id":"A380","pred":"chebi_id","subj":"T380","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T217","span":{"begin":10,"end":12},"obj":"Chemical"}],"attributes":[{"id":"A217","pred":"chebi_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T133","span":{"begin":132,"end":140},"obj":"Species"}],"attributes":[{"id":"A133","pred":"ncbi_taxonomy_id","subj":"T133","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T251","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1339","span":{"begin":118,"end":126},"obj":"Species"},{"id":"1366","span":{"begin":10,"end":12},"obj":"Chemical"},{"id":"1404","span":{"begin":64,"end":99},"obj":"Disease"},{"id":"1405","span":{"begin":103,"end":117},"obj":"Disease"},{"id":"1406","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A1339","pred":"pubann:denotes","subj":"1339","obj":"Tax:9606"},{"id":"A1366","pred":"pubann:denotes","subj":"1366","obj":"MESH:D002738"},{"id":"A1404","pred":"pubann:denotes","subj":"1404","obj":"MESH:D008133"},{"id":"A1405","pred":"pubann:denotes","subj":"1405","obj":"MESH:D016638"},{"id":"A1406","pred":"pubann:denotes","subj":"1406","obj":"MESH:C000657245"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T137","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A137","pred":"mondo_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1339","span":{"begin":118,"end":126},"obj":"Species"},{"id":"1366","span":{"begin":10,"end":12},"obj":"Chemical"},{"id":"1404","span":{"begin":64,"end":99},"obj":"Disease"},{"id":"1405","span":{"begin":103,"end":117},"obj":"Disease"},{"id":"1406","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A1339","pred":"tao:has_database_id","subj":"1339","obj":"Tax:9606"},{"id":"A1366","pred":"tao:has_database_id","subj":"1366","obj":"MESH:D002738"},{"id":"A1404","pred":"tao:has_database_id","subj":"1404","obj":"MESH:D008133"},{"id":"A1405","pred":"tao:has_database_id","subj":"1405","obj":"MESH:D016638"},{"id":"A1406","pred":"tao:has_database_id","subj":"1406","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}

{"project":"LitCovid-sentences","denotations":[{"id":"T251","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"High-dose CQ (600 mg/2 times/day for 10 day) is associated with increased QTc interval prolongation in critically ill patients with COVID-19 [49] and should not be recommended."}